Dr. Alejandro Soza  (@alejandrosoza) 's Twitter Profile
Dr. Alejandro Soza 

@alejandrosoza

Hepatólogo. Profesor Titular, Pontificia Universidad Católica de Chile. hepatitis.cl

ID: 17377977

linkhttp://hepatitis.cl calendar_today14-11-2008 01:59:01

2,2K Tweet

3,3K Followers

1,1K Following

Dr. Alejandro Soza  (@alejandrosoza) 's Twitter Profile Photo

🧬 Primer tratamiento con #CRISPR busca aprobación de la FDA 🇺🇸 para combatir anemia falciforme y β-talasemia 😱💉 ¡Es solo el comienzo de una revolución en medicina! 🚀 #TerapiaGenética 🌎👩‍🔬🧪 nature.com/articles/d4157…

Juan G Abraldes (@juanabraldes) 's Twitter Profile Photo

1/3 Was the bar of evidence too low to recommend carvedilol for preventing decomp in AASLD guidance? To benchmark this: In MASH one positive trial on a surrogate (histology) in F2-F3 + one positive on clinical outcomes in F4 --> full approval F2-F4. George Ioannou

Juan Pablo (JP) Arab, MD  (@juanpabloarab) 's Twitter Profile Photo

I am very grateful to have been able to collaborate in this The Lancet Seminar on Acute Liver Failure with Rakhi Maiwall Anand V Kulkarni Salvatore Piano Very important topic, hope you find it useful and informative 👉 Acute liver failure (ALF) is a life-threatening disorder

I am very grateful to have been able to collaborate in this <a href="/TheLancet/">The Lancet</a> Seminar on Acute Liver Failure with <a href="/MaiwallRakhi/">Rakhi Maiwall</a> <a href="/AnandVKulkarni2/">Anand V Kulkarni</a> <a href="/salvatore_piano/">Salvatore Piano</a> 
Very important topic, hope you find it useful and informative
👉 Acute liver failure (ALF) is a life-threatening disorder
Juan Pablo (JP) Arab, MD  (@juanpabloarab) 's Twitter Profile Photo

I am glad that this is on the news. We have known this for a number of years. Alcohol (even small amounts) increases the risk of liver disease, cardiovascular disease and cancer, among others. Here our recent article: pubmed.ncbi.nlm.nih.gov/37992972/ #ALDsig #ALDcure #LiverTwitter #LiverX

I am glad that this is on the news. We have known this for a number of years. Alcohol (even small amounts) increases the risk of liver disease, cardiovascular disease and cancer, among others.
Here our recent article:
pubmed.ncbi.nlm.nih.gov/37992972/
#ALDsig #ALDcure #LiverTwitter #LiverX
Dr. Alejandro Soza  (@alejandrosoza) 's Twitter Profile Photo

La eliminación de las hepatitis virales en Latinoamérica no será posible sin datos, cooperación y acción decidida. REVIRAL ofrece exactamente eso: articulación regional y un llamado urgente a los tomadores de decisión.

VCU Stravitz-Sanyal Institute for Liver Disease (@vcu_liver) 's Twitter Profile Photo

Join us May 28 for a presentation by Luis Antonio Díaz, MD, of UC San Diego, on “MetALD: Bridging the Gap Between Metabolic Dysfunction and Alcohol-Associated Liver Disease.” Register at bit.ly/3GKSB5O #livertwitter

Join us May 28 for a presentation by <a href="/LuisAntonioDiaz/">Luis Antonio Díaz, MD</a>, of
UC San Diego, on “MetALD: Bridging the Gap Between Metabolic Dysfunction and Alcohol-Associated Liver Disease.” Register at bit.ly/3GKSB5O #livertwitter
Manuel Mendizabal (@mmendizabalmd) 's Twitter Profile Photo

In 2024 WHO released new guidelines to simplify Hep B treatment 👉 We assessed treatment expansion by comparing country-specific vs WHO guidelines in South America 🚨 Result: a 10.4% increase in treatment eligibility, significantly higher among women 🔒shorturl.at/iLmNv

In 2024 WHO released new guidelines to simplify Hep B treatment

👉 We assessed treatment expansion by comparing country-specific vs WHO guidelines in South America

🚨 Result: a 10.4% increase in treatment eligibility, significantly higher among women

🔒shorturl.at/iLmNv
Dr. Alejandro Soza  (@alejandrosoza) 's Twitter Profile Photo

🎓 Webinar gratuito Te invito a participar en una interesante sesión sobre el manejo y seguimiento de la esteatosis hepática y la enfermedad hepática por alcohol. 🗓 Jueves 3 de julio | 🕖 19:00 hrs | 📍 YouTube 🔗 Inscripción gratuita: forms.office.com/r/zkr4BTFvpw ¡Te esperamos!

🎓 Webinar gratuito
Te invito a participar en una interesante sesión sobre el manejo y seguimiento de la esteatosis hepática y la enfermedad hepática por alcohol.

🗓 Jueves 3 de julio | 🕖 19:00 hrs | 📍 YouTube

🔗 Inscripción gratuita: forms.office.com/r/zkr4BTFvpw

¡Te esperamos!